46/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0. Gray context columns never affect the score. CEO quarterly pay is the explicitly marked annual ÷ 4 estimate.
Trailing 1 year (4 quarters): 4 wins, 8 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly. Unavailable evidence scores 0 only in Win/Lose columns; gray columns award no points.
| Quarter | Total return | Revenue growth | EPS growth | Net marginNon-scoring | Trailing P/ENon-scoring | Price/bookNon-scoring | CEO quarterly payNon-scoring | Implied DilutionNon-scoring | Implied BuybackNon-scoring |
|---|---|---|---|---|---|---|---|---|---|
| 2026-Q20/3 |
LoseEYE / S&P -26.60% / 15.20% |
LoseEYE / S&P 7.84% / 15.00% |
LoseEYE / S&P -438.89% / 50.40% |
Non-scoringEYE / S&P 2.47% / 15.70% | Non-scoringEYE / S&P 31.07 / 28.47 | Non-scoringEYE / S&P 1.74 / S&P unavailable | Non-scoringEYE / S&P EYE unavailable / S&P unavailable | Non-scoringEYE / S&P EYE unavailable / $0.00b | Non-scoringEYE / S&P EYE unavailable / $0.36b |
| 2026-Q11/3 |
WinEYE / S&P 0.31% / -4.33% |
LoseEYE / S&P 9.20% / 11.30% |
LoseEYE / S&P -272.73% / 27.70% |
Non-scoringEYE / S&P 2.31% / 14.80% | Non-scoringEYE / S&P 40.73 / 25.43 | Non-scoringEYE / S&P 2.11 / S&P unavailable | Non-scoringEYE / S&P EYE unavailable / S&P unavailable | Non-scoringEYE / S&P EYE unavailable / $0.27b | Non-scoringEYE / S&P EYE unavailable / $0.00b |
| 2025-Q41/3 |
LoseEYE / S&P -11.55% / 2.65% |
WinEYE / S&P 9.00% / 9.00% |
LoseEYE / S&P -202.78% / 13.40% |
Non-scoringEYE / S&P 1.49% / 13.20% | Non-scoringEYE / S&P 69.62 / 28.48 | Non-scoringEYE / S&P 2.37 / 5.39 | Non-scoringEYE / S&P EYE unavailable / $4.42m | Non-scoringEYE / S&P EYE unavailable / $0.00b | Non-scoringEYE / S&P EYE unavailable / $0.20b |
| 2025-Q32/3 |
WinEYE / S&P 26.86% / 8.12% |
WinEYE / S&P 6.33% / 4.61% |
LoseEYE / S&P -85.71% / 13.45% |
Non-scoringEYE / S&P -0.12% / 11.78% | Non-scoringEYE / S&P EYE unavailable / 28.13 | Non-scoringEYE / S&P 2.63 / 5.27 | Non-scoringEYE / S&P EYE unavailable / $4.42m | Non-scoringEYE / S&P EYE unavailable / $0.11b | Non-scoringEYE / S&P EYE unavailable / $0.00b |
| 2025-Q22/3 |
WinEYE / S&P 80.05% / 10.94% |
WinEYE / S&P 5.08% / 4.83% |
LoseEYE / S&P -82.69% / 10.63% |
Non-scoringEYE / S&P -0.75% / 11.45% | Non-scoringEYE / S&P EYE unavailable / 27.10 | Non-scoringEYE / S&P 2.16 / 5.01 | Non-scoringEYE / S&P EYE unavailable / $4.42m | Non-scoringEYE / S&P EYE unavailable / $0.00b | Non-scoringEYE / S&P EYE unavailable / $0.23b |
| 2025-Q11/3 |
WinEYE / S&P 22.65% / -4.27% |
LoseEYE / S&P 4.31% / 4.98% |
LoseEYE / S&P -64.52% / 10.57% |
Non-scoringEYE / S&P -1.40% / 11.39% | Non-scoringEYE / S&P EYE unavailable / 26.23 | Non-scoringEYE / S&P 1.21 / 4.69 | Non-scoringEYE / S&P EYE unavailable / $4.42m | Non-scoringEYE / S&P EYE unavailable / $0.00b | Non-scoringEYE / S&P EYE unavailable / $0.10b |
| 2024-Q40/3 |
LoseEYE / S&P -4.49% / 2.41% |
LoseEYE / S&P 0.60% / 5.25% |
LoseEYE / S&P -58.14% / 6.15% |
Non-scoringEYE / S&P -1.56% / 11.29% | Non-scoringEYE / S&P EYE unavailable / 28.60 | Non-scoringEYE / S&P 1.02 / 4.99 | Non-scoringEYE / S&P EYE unavailable / $4.28m | Non-scoringEYE / S&P EYE unavailable / $0.00b | Non-scoringEYE / S&P EYE unavailable / $0.08b |
| 2024-Q31/3 |
LoseEYE / S&P -16.65% / 5.89% |
WinEYE / S&P 20.50% / 5.89% |
LoseEYE / S&P -72.37% / 6.11% |
Non-scoringEYE / S&P -0.88% / 10.87% | Non-scoringEYE / S&P EYE unavailable / 28.09 | Non-scoringEYE / S&P 1.03 / 4.94 | Non-scoringEYE / S&P EYE unavailable / $4.28m | Non-scoringEYE / S&P EYE unavailable / $0.00b | Non-scoringEYE / S&P EYE unavailable / $0.21b |
| 2024-Q21/3 |
LoseEYE / S&P -40.93% / 4.28% |
WinEYE / S&P 15.02% / 5.38% |
LoseEYE / S&P -415.15% / 5.12% |
Non-scoringEYE / S&P -4.53% / 10.85% | Non-scoringEYE / S&P EYE unavailable / 27.64 | Non-scoringEYE / S&P 1.22 / 4.79 | Non-scoringEYE / S&P EYE unavailable / $4.28m | Non-scoringEYE / S&P EYE unavailable / $0.00b | Non-scoringEYE / S&P EYE unavailable / $0.36b |
| 2024-Q11/3 |
LoseEYE / S&P 5.88% / 10.56% |
WinEYE / S&P 8.34% / 5.71% |
LoseEYE / S&P -344.74% / 5.59% |
Non-scoringEYE / S&P -4.09% / 10.81% | Non-scoringEYE / S&P EYE unavailable / 27.02 | Non-scoringEYE / S&P 2.07 / 4.71 | Non-scoringEYE / S&P EYE unavailable / $4.28m | Non-scoringEYE / S&P EYE unavailable / $0.00b | Non-scoringEYE / S&P EYE unavailable / $0.12b |
| 2023-Q42/3 |
WinEYE / S&P 29.36% / 11.69% |
WinEYE / S&P 10.20% / 6.81% |
LoseEYE / S&P -272.00% / 7.78% |
Non-scoringEYE / S&P -3.64% / 11.19% | Non-scoringEYE / S&P EYE unavailable / 24.35 | Non-scoringEYE / S&P 1.98 / 4.31 | Non-scoringEYE / S&P EYE unavailable / $4.08m | Non-scoringEYE / S&P EYE unavailable / $0.00b | Non-scoringEYE / S&P EYE unavailable / $0.01b |
| 2023-Q30/3 |
LoseEYE / S&P -33.39% / -3.27% |
LoseEYE / S&P -25.55% / 7.52% |
LoseEYE / S&P -208.57% / -5.03% |
Non-scoringEYE / S&P -3.95% / 10.84% | Non-scoringEYE / S&P EYE unavailable / 23.93 | Non-scoringEYE / S&P 1.51 / 3.98 | Non-scoringEYE / S&P EYE unavailable / $4.08m | Non-scoringEYE / S&P EYE unavailable / $0.00b | Non-scoringEYE / S&P EYE unavailable / $0.24b |
| 2023-Q21/3 |
WinEYE / S&P 28.93% / 8.74% |
LoseEYE / S&P -23.27% / 9.50% |
LoseEYE / S&P -67.00% / -8.57% |
Non-scoringEYE / S&P 1.67% / 10.88% | Non-scoringEYE / S&P 72.66 / 24.01 | Non-scoringEYE / S&P 2.09 / 4.19 | Non-scoringEYE / S&P EYE unavailable / $4.08m | Non-scoringEYE / S&P EYE unavailable / $0.00b | Non-scoringEYE / S&P EYE unavailable / $0.17b |
| 2023-Q10/3 |
LoseEYE / S&P -51.39% / 7.50% |
LoseEYE / S&P -21.00% / 10.77% |
LoseEYE / S&P -70.77% / -15.69% |
Non-scoringEYE / S&P 1.85% / 10.82% | Non-scoringEYE / S&P 48.64 / 22.66 | Non-scoringEYE / S&P 1.64 / 3.93 | Non-scoringEYE / S&P EYE unavailable / $4.08m | Non-scoringEYE / S&P EYE unavailable / $0.00b | Non-scoringEYE / S&P EYE unavailable / $0.13b |
| 2022-Q41/3 |
WinEYE / S&P 18.71% / 7.56% |
LoseEYE / S&P -20.91% / 11.88% |
LoseEYE / S&P -65.28% / -17.99% |
Non-scoringEYE / S&P 2.56% / 11.09% | Non-scoringEYE / S&P 72.69 / 22.65 | Non-scoringEYE / S&P 3.40 / 3.75 | Non-scoringEYE / S&P EYE unavailable / $3.70m | Non-scoringEYE / S&P EYE unavailable / $0.00b | Non-scoringEYE / S&P EYE unavailable / $0.15b |
| 2022-Q31/3 |
WinEYE / S&P 18.73% / -4.88% |
LoseEYE / S&P -4.01% / 13.47% |
LoseEYE / S&P -60.67% / -1.41% |
Non-scoringEYE / S&P 2.86% / 12.28% | Non-scoringEYE / S&P 44.73 / 20.58 | Non-scoringEYE / S&P 2.84 / 3.60 | Non-scoringEYE / S&P EYE unavailable / $3.70m | Non-scoringEYE / S&P EYE unavailable / $0.00b | Non-scoringEYE / S&P EYE unavailable / $0.17b |
| 2022-Q20/3 |
LoseEYE / S&P -36.88% / -16.10% |
LoseEYE / S&P -1.58% / 13.71% |
LoseEYE / S&P -42.86% / 11.04% |
Non-scoringEYE / S&P 4.28% / 13.03% | Non-scoringEYE / S&P 25.45 / 20.28 | Non-scoringEYE / S&P 2.49 / 3.78 | Non-scoringEYE / S&P EYE unavailable / $3.70m | Non-scoringEYE / S&P EYE unavailable / $0.00b | Non-scoringEYE / S&P EYE unavailable / $0.17b |
| 2022-Q12/3 |
LoseEYE / S&P -9.21% / -4.60% |
WinEYE / S&P 16.71% / 15.97% |
WinEYE / S&P 66.67% / 42.23% |
Non-scoringEYE / S&P 5.55% / 14.22% | Non-scoringEYE / S&P 31.47 / 22.19 | Non-scoringEYE / S&P 3.81 / 4.51 | Non-scoringEYE / S&P EYE unavailable / $3.70m | Non-scoringEYE / S&P EYE unavailable / $0.00b | Non-scoringEYE / S&P EYE unavailable / $0.20b |
| 2021-Q42/3 |
LoseEYE / S&P -15.47% / 11.03% |
WinEYE / S&P 21.48% / 15.00% |
WinEYE / S&P 242.86% / 96.40% |
Non-scoringEYE / S&P 6.17% / 15.13% | Non-scoringEYE / S&P 30.46 / 23.63 | Non-scoringEYE / S&P 4.22 / 4.73 | Non-scoringEYE / S&P EYE unavailable / $3.63m | Non-scoringEYE / S&P EYE unavailable / $0.00b | Non-scoringEYE / S&P EYE unavailable / $0.13b |
| 2021-Q33/3 |
WinEYE / S&P 11.03% / 0.58% |
WinEYE / S&P 29.78% / 10.77% |
WinEYE / S&P 4350.00% / 69.42% |
Non-scoringEYE / S&P 7.49% / 14.13% | Non-scoringEYE / S&P 29.15 / 25.35 | Non-scoringEYE / S&P 4.63 / 4.38 | Non-scoringEYE / S&P EYE unavailable / $3.63m | Non-scoringEYE / S&P EYE unavailable / $0.00b | Non-scoringEYE / S&P EYE unavailable / $0.19b |
| 2021-Q22/3 |
WinEYE / S&P 16.66% / 8.55% |
WinEYE / S&P 32.13% / 6.58% |
LoseEYE / S&P -572.97% / 51.81% |
Non-scoringEYE / S&P 7.33% / 13.34% | Non-scoringEYE / S&P 27.45 / 26.70 | Non-scoringEYE / S&P 4.43 / 4.43 | Non-scoringEYE / S&P EYE unavailable / $3.63m | Non-scoringEYE / S&P EYE unavailable / $0.00b | Non-scoringEYE / S&P EYE unavailable / $0.11b |
| 2021-Q12/3 |
LoseEYE / S&P -3.22% / 6.17% |
WinEYE / S&P 2.51% / -1.06% |
WinEYE / S&P 151.61% / 7.39% |
Non-scoringEYE / S&P 3.94% / 11.60% | Non-scoringEYE / S&P 52.55 / 30.50 | Non-scoringEYE / S&P 4.14 / 4.23 | Non-scoringEYE / S&P EYE unavailable / $3.63m | Non-scoringEYE / S&P EYE unavailable / $0.00b | Non-scoringEYE / S&P EYE unavailable / $0.10b |
| 2020-Q43/3 |
WinEYE / S&P 18.44% / 12.15% |
WinEYE / S&P -0.73% / -3.72% |
WinEYE / S&P 5.00% / -33.42% |
Non-scoringEYE / S&P 2.12% / 8.86% | Non-scoringEYE / S&P 101.42 / 39.26 | Non-scoringEYE / S&P 4.06 / 4.05 | Non-scoringEYE / S&P EYE unavailable / $3.17m | Non-scoringEYE / S&P EYE unavailable / $0.00b | Non-scoringEYE / S&P EYE unavailable / $0.01b |
| 2020-Q31/3 |
WinEYE / S&P 25.29% / 8.93% |
LoseEYE / S&P -3.67% / -2.04% |
LoseEYE / S&P -63.64% / -27.10% |
Non-scoringEYE / S&P 0.32% / 9.24% | Non-scoringEYE / S&P 583.24 / 34.27 | Non-scoringEYE / S&P 3.45 / 3.65 | Non-scoringEYE / S&P EYE unavailable / $3.17m | Non-scoringEYE / S&P EYE unavailable / $0.02b | Non-scoringEYE / S&P EYE unavailable / $0.00b |
| 2020-Q21/3 |
WinEYE / S&P 57.16% / 20.54% |
LoseEYE / S&P -4.32% / -0.46% |
LoseEYE / S&P -331.25% / -27.11% |
Non-scoringEYE / S&P -1.85% / 9.37% | Non-scoringEYE / S&P EYE unavailable / 31.29 | Non-scoringEYE / S&P 2.82 / 3.44 | Non-scoringEYE / S&P EYE unavailable / $3.17m | Non-scoringEYE / S&P EYE unavailable / $0.00b | Non-scoringEYE / S&P EYE unavailable / $0.03b |
| 2020-Q12/3 |
LoseEYE / S&P -40.12% / -19.60% |
WinEYE / S&P 8.98% / 3.47% |
WinEYE / S&P 63.16% / -14.75% |
Non-scoringEYE / S&P 1.45% / 10.68% | Non-scoringEYE / S&P 63.72 / 22.80 | Non-scoringEYE / S&P 2.04 / 2.92 | Non-scoringEYE / S&P EYE unavailable / $3.17m | Non-scoringEYE / S&P EYE unavailable / $0.00b | Non-scoringEYE / S&P EYE unavailable / $0.05b |
| 2019-Q43/3 |
WinEYE / S&P 34.73% / 9.07% |
WinEYE / S&P 12.20% / 5.36% |
WinEYE / S&P 37.93% / 2.99% |
Non-scoringEYE / S&P 1.90% / 12.81% | Non-scoringEYE / S&P 80.41 / 22.78 | Non-scoringEYE / S&P 3.40 / 3.53 | Non-scoringEYE / S&P EYE unavailable / $3.08m | Non-scoringEYE / S&P EYE unavailable / $0.00b | Non-scoringEYE / S&P EYE unavailable / $0.05b |
| 2019-Q31/3 |
LoseEYE / S&P -21.67% / 1.70% |
WinEYE / S&P 11.69% / 5.02% |
LoseEYE / S&P -88.30% / 0.21% |
Non-scoringEYE / S&P 0.62% / 12.41% | Non-scoringEYE / S&P 181.16 / 22.44 | Non-scoringEYE / S&P 2.47 / 3.30 | Non-scoringEYE / S&P EYE unavailable / $3.08m | Non-scoringEYE / S&P EYE unavailable / $0.00b | Non-scoringEYE / S&P EYE unavailable / $0.09b |
| 2019-Q21/3 |
LoseEYE / S&P -2.23% / 4.30% |
WinEYE / S&P 11.81% / 6.64% |
LoseEYE / S&P -82.42% / 8.65% |
Non-scoringEYE / S&P 0.88% / 12.79% | Non-scoringEYE / S&P 167.29 / 21.37 | Non-scoringEYE / S&P 3.11 / 3.32 | Non-scoringEYE / S&P EYE unavailable / $3.08m | Non-scoringEYE / S&P EYE unavailable / $0.00b | Non-scoringEYE / S&P EYE unavailable / $0.27b |
| 2019-Q11/3 |
LoseEYE / S&P 11.57% / 13.65% |
WinEYE / S&P 12.50% / 8.12% |
LoseEYE / S&P -73.61% / 14.29% |
Non-scoringEYE / S&P 1.05% / 12.97% | Non-scoringEYE / S&P 147.86 / 20.86 | Non-scoringEYE / S&P 3.22 / 3.26 | Non-scoringEYE / S&P EYE unavailable / $3.08m | Non-scoringEYE / S&P EYE unavailable / $0.00b | Non-scoringEYE / S&P EYE unavailable / $34.35b |
| 2018-Q41/3 |
LoseEYE / S&P -37.59% / -13.52% |
WinEYE / S&P 11.75% / 9.05% |
LoseEYE / S&P -58.57% / 18.23% |
Non-scoringEYE / S&P 1.54% / 13.10% | Non-scoringEYE / S&P 95.77 / 19.39 | Non-scoringEYE / S&P 3.05 / 2.94 | Non-scoringEYE / S&P EYE unavailable / $3.00m | Non-scoringEYE / S&P EYE unavailable / $0.01b | Non-scoringEYE / S&P EYE unavailable / $0.00b |
| 2018-Q33/3 |
WinEYE / S&P 23.43% / 7.71% |
WinEYE / S&P 12.94% / 10.21% |
WinEYE / S&P 944.44% / 19.06% |
Non-scoringEYE / S&P 4.53% / 13.01% | Non-scoringEYE / S&P 51.09 / 22.25 | Non-scoringEYE / S&P 4.63 / 3.45 | Non-scoringEYE / S&P EYE unavailable / $3.00m | Non-scoringEYE / S&P EYE unavailable / $0.00b | Non-scoringEYE / S&P EYE unavailable / $0.17b |
| 2018-Q23/3 |
WinEYE / S&P 13.18% / 3.43% |
WinEYE / S&P 13.66% / 9.03% |
WinEYE / S&P 727.27% / 14.46% |
Non-scoringEYE / S&P 4.41% / 12.56% | Non-scoringEYE / S&P 42.72 / 22.49 | Non-scoringEYE / S&P 3.81 / 3.25 | Non-scoringEYE / S&P EYE unavailable / $3.00m | Non-scoringEYE / S&P EYE unavailable / $0.00b | Non-scoringEYE / S&P EYE unavailable / $0.19b |
| 2018-Q10/3 |
LoseEYE / S&P -20.44% / -0.76% |
LoseEYE / S&P EYE unavailable / 7.68% |
LoseEYE / S&P EYE unavailable / 12.46% |
Non-scoringEYE / S&P 3.57% / 12.27% | Non-scoringEYE / S&P 48.03 / 23.41 | Non-scoringEYE / S&P 3.44 / 3.17 | Non-scoringEYE / S&P EYE unavailable / $3.00m | Non-scoringEYE / S&P EYE unavailable / $0.00b | Non-scoringEYE / S&P EYE unavailable / $0.08b |
| 2017-Q40/3 |
LoseEYE / S&P EYE unavailable / 6.64% |
LoseEYE / S&P EYE unavailable / 7.03% |
LoseEYE / S&P EYE unavailable / 13.82% |
Non-scoringEYE / S&P 3.14% / 12.09% | Non-scoringEYE / S&P 70.28 / 24.25 | Non-scoringEYE / S&P 4.47 / 3.23 | Non-scoringEYE / S&P EYE unavailable / $2.92m | Non-scoringEYE / S&P EYE unavailable / $0.00b | Non-scoringEYE / S&P EYE unavailable / $0.05b |
| 2017-Q30/3 |
LoseEYE / S&P EYE unavailable / 4.48% |
LoseEYE / S&P EYE unavailable / 5.68% |
LoseEYE / S&P EYE unavailable / 17.57% |
Non-scoringEYE / S&P 0.45% / 12.04% | Non-scoringEYE / S&P EYE unavailable / 23.28 | Non-scoringEYE / S&P EYE unavailable / 3.08 | Non-scoringEYE / S&P EYE unavailable / $2.92m | Non-scoringEYE / S&P EYE unavailable / $0.00b | Non-scoringEYE / S&P EYE unavailable / $0.11b |
| 2017-Q20/3 |
LoseEYE / S&P EYE unavailable / 3.09% |
LoseEYE / S&P EYE unavailable / 4.83% |
LoseEYE / S&P EYE unavailable / 17.74% |
Non-scoringEYE / S&P 0.58% / 11.96% | Non-scoringEYE / S&P EYE unavailable / 23.40 | Non-scoringEYE / S&P EYE unavailable / 3.03 | Non-scoringEYE / S&P EYE unavailable / $2.92m | Non-scoringEYE / S&P EYE unavailable / $0.00b | Non-scoringEYE / S&P EYE unavailable / $0.08b |
| 2017-Q10/3 |
LoseEYE / S&P EYE unavailable / 6.07% |
LoseEYE / S&P EYE unavailable / 3.67% |
LoseEYE / S&P EYE unavailable / 13.32% |
Non-scoringEYE / S&P EYE unavailable / 11.75% | Non-scoringEYE / S&P EYE unavailable / 23.60 | Non-scoringEYE / S&P EYE unavailable / 3.01 | Non-scoringEYE / S&P EYE unavailable / $2.92m | Non-scoringEYE / S&P EYE unavailable / $0.00b | Non-scoringEYE / S&P EYE unavailable / $20.24b |
| 2016-Q40/3 |
LoseEYE / S&P EYE unavailable / 3.82% |
LoseEYE / S&P EYE unavailable / 2.09% |
LoseEYE / S&P EYE unavailable / 7.05% |
Non-scoringEYE / S&P EYE unavailable / 11.37% | Non-scoringEYE / S&P EYE unavailable / 23.76 | Non-scoringEYE / S&P EYE unavailable / 2.91 | Non-scoringEYE / S&P EYE unavailable / $2.88m | Non-scoringEYE / S&P EYE unavailable / $0.00b | Non-scoringEYE / S&P EYE unavailable / $1.11b |
| 2016-Q30/3 |
LoseEYE / S&P EYE unavailable / 3.85% |
LoseEYE / S&P EYE unavailable / 0.20% |
LoseEYE / S&P EYE unavailable / -3.15% |
Non-scoringEYE / S&P EYE unavailable / 10.82% | Non-scoringEYE / S&P EYE unavailable / 24.22 | Non-scoringEYE / S&P EYE unavailable / 2.78 | Non-scoringEYE / S&P EYE unavailable / $2.88m | Non-scoringEYE / S&P EYE unavailable / $0.00b | Non-scoringEYE / S&P EYE unavailable / $0.16b |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | EYE total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -22.10% | 20.78% |
| Annualized return | -22.10% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | EYE total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -70.10% | 83.14% |
| Annualized return | -21.45% | 12.86% |
10Y · 2017-10-27 to 2026-08-27
| Metric | EYE total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -36.52% | 319.30% |
| Annualized return | -4.44% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
- Net margin, P/E, P/B and other gray context columns never enter the score.
Snapshot captured 2026-09-04.